Nivolumab is an anti-programmed cell death protein 1 monoclonal antibody that is used to treat metastatic cutaneous malignant melanoma. Although bilateral uveitis has been reported as a side effect of nivolumab administration. there are few reports of Vogt-Koyanagi-Harada disease (VKH)-like uveitis. We report such a case. https://ashleyshomestores.shop/product-category/3-piece-reclining-sectional-with-chaise/